✦ LIBER ✦

Use of Platelet Glycoprotein IIb/IIIa Inhibitors in Saphenous Vein Graft Percutaneous Coronary Intervention and Clinical Outcomes

✍ Scribed by Juhana Karha; Hitinder S. Gurm; Vivek Rajagopal; Robert Fathi; Anthony A. Bavry; Sorin J. Brener; A. Michael Lincoff; Stephen G. Ellis; Deepak L. Bhatt

Book ID: 113443180
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 204 KB
Volume: 98
Category: Article
ISSN: 0002-9149
DOI: 10.1016/j.amjcard.2006.04.037

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Planned Versus Provisional Use of Glycop

Planned Versus Provisional Use of Glycoprotein IIb/IIIa Inhibitors in Smokers Undergoing Percutaneous Coronary Intervention

✍ Jason O. Robertson; A. Michael Lincoff; Kathy Wolski; Eric J. Topol 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 127 KB

Comparison of Bivalirudin Versus Bivalir

Comparison of Bivalirudin Versus Bivalirudin Plus Glycoprotein IIb/IIIa Inhibitor Versus Heparin Plus Glycoprotein IIb/IIIa Inhibitor in Patients With Acute Coronary Syndromes Having Percutaneous Intervention for Narrowed Saphenous Vein Aorto-Coronary Grafts (the ACUITY Trial Investigators)

✍ Dinesh Kumar; George Dangas; Roxana Mehran; Ajay Kirtane; Michel Bertrand; Ramin 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 152 KB

Direct Thrombin Inhibitors for Percutane

Direct Thrombin Inhibitors for Percutaneous Coronary Intervention in the Current Era of Platelet Glycoprotein IIb/IIIa Inhibition

✍ JOEL P. REGINELLI; DEREK CHEW 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 507 KB

Impact of platelet glycoprotein IIb/IIIa

Impact of platelet glycoprotein IIb/IIIa receptor inhibitors on outcomes of diabetic patients undergoing percutaneous coronary interventions using sirolimus-eluting stents

✍ Eugenia Nikolsky; David R. Holmes; Roxana Mehran; George Dangas; Erick Schampaer 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 188 KB 👁 2 views

A propensity analysis of the impact of p

A propensity analysis of the impact of platelet glycoprotein IIb/IIIa inhibitor therapy on in-hospital outcomes after percutaneous coronary intervention

✍ Samin K. Sharma 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 111 KB

A propensity analysis of the impact of p

A propensity analysis of the impact of platelet glycoprotein IIb/IIIa inhibitor therapy on in-hospital outcomes after percutaneous coronary intervention

✍ Babak A Vakili; Robert C Kaplan; James N Slater; Warren Sherman; Kumar L Ravi; S 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 74 KB